P

Progyny

Fertility benefits management for employers

Vice President - Client Success, Health Plan Market Leader

Full-Time
$180k - $195k/yr+ Bonus program + Company equity
Expert
New York, NY, USA
HybridThree days a week in the office for employees reporting into the New York office.
Customer Experience & SupportCustomer Success
No H1B Sponsorship

About the job

Requirements
  • At least 10 years of leadership experience within healthcare, employer benefits, or insurance industries.
  • Experience building and managing a high-performing Health Plan client success, account management, strategic partnerships, or payer-facing team.
  • Experience working with health plans, payers, strategic channel partners, healthcare benefits organizations, or similarly complex enterprise healthcare relationships.
  • Strong understanding of payer stakeholder dynamics, including executive sponsors, account management, clinical, operations, product, compliance, reporting, and network-related teams.
  • Ability to translate complex operational, clinical, financial, utilization, and member experience data into clear executive-level insights and recommendations.
  • Demonstrated success supporting retention, expansion, renewals, and strategic account growth.
  • Ability to tailor written and verbal communication for payer executives, internal leadership, consultants, cross-functional partners, and team members.
  • Ability to identify, build strong relationships with, and effectively leverage internal and external resources to solve complex client and partner needs.
  • Ability to operate under pressure, manage ambiguity, prioritize competing responsibilities, and drive decisions in a fast-paced, evolving market segment.
  • Attention to detail and ability to implement performance management, KPI tracking, and accountability processes that support team and market goals.
  • Must be based in the United States and authorized to work in the United States without current or future sponsorship.
Responsibilities
  • Lead and manage the Health Plan Client Success team, establishing annual goals tied to retention, client satisfaction, growth, operational performance, and partner engagement.
  • Develop and implement Health Plan-specific client success processes, operating cadences, and business practices that support retention, expansion, renewal strategy, and escalated issue management.
  • Represent Progyny in executive-level health plan meetings, business reviews, partner discussions, and industry events to strengthen relationships, reinforce Progyny’s value proposition, and support long-term strategic alignment.
  • Articulate Progyny’s value to health plan executives, strategic partners, consultants, operational stakeholders, and internal leaders; translate data-driven financial, clinical, utilization, and member experience insights into renewal, reporting, and growth narratives.
  • Partner with Sales, Product, Operations, Analytics, Legal, Compliance, Finance, and Marketing to support health plan implementations, renewals, reporting needs, product adoption, market expansion opportunities, and resolution of partner-specific issues.
  • Help resolve member, client, and partner escalations routed through the Health Plan Client Success team; work with senior leaders and cross-functional partners to identify root causes, determine corrective actions, and develop communication plans.
  • Partner with senior leadership to build and manage a scalable Health Plan staffing model and team structure that supports portfolio complexity, growth expectations, service model evolution, and market needs.
  • Refine and operationalize a Health Plan partnership approach that clarifies relationship ownership, executive engagement, reporting standards, internal handoffs, service expectations, and success metrics.
  • Drive retention and growth within the existing Health Plan client and partner base by identifying expansion opportunities across populations, lines of business, geographies, products, services, and strategic use cases.
  • Guide, coach, and develop Client Success leaders and team members supporting Health Plan clients, ensuring they have payer-market knowledge, consultative skills, operational discipline, and executive presence.
  • Propose and build, with Operational support, team infrastructure, playbooks, and operating cadences that support consistency, scalability, accountability, and strong cross-functional partnership across the Health Plan portfolio.
  • Create a culture of strategic client advocacy, business ownership, transparency, and continuous improvement while balancing client needs, operational realities, compliance considerations, and Progyny’s business objectives.

About the company

P

Progyny

View
Website

Progyny is a fertility benefits manager that partners with employers to offer comprehensive fertility and family-building services to employees. It provides a wide range of services including IUI, IVF, fertility preservation, adoption assistance, and surrogacy support, all integrated into employers’ existing benefits packages. The company makes money by signing contracts with employers, typically using a fixed-fee or per-employee-per-month pricing model, and it works to deliver better clinical outcomes to reduce overall treatment costs. Unlike broader health insurers, Progyny focuses specifically on fertility care and family-building, emphasizing measurable clinical results and seamless workflow within the benefits ecosystem. Its goal is to expand access to inclusive fertility benefits while improving outcomes and controlling costs for employers and employees.

Company Size

501-1,000

Company Stage

IPO

Headquarters

New York City, New York

Founded

2008

Get referred to Progyny

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $350.5 million, with gross margin expanding to 25.5%.
  • Progyny repurchased 10.8 million shares since November 2025, supporting per-share economics.
  • Provider-search recognition for FertilityEquity strengthens network quality and member trust into 2027.

What critics are saying

  • Q2 2026 growth still lapped a $48.5 million transition client wind-down.
  • August 2026 guidance disappointed investors; shares fell after lower third-quarter expectations.
  • Carrot Fertility and Maven Clinic pressure pricing; employers can bundle fertility elsewhere by 2027.

What makes Progyny unique

  • Progyny owns employer fertility navigation, specialty networks, and care advocates.
  • FertilityEquity and provider search make culturally responsive care visible to members.
  • Progyny Select extends coverage to smaller employers through brokers for 2027 plan years.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Unlimited Paid Time Off
  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Company Equity

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
Military Industry Today
Oct 15th, 2026
Progyny to present new menopause research at The Menopause Society 2026 Annual Meeting.

Progyny to present new menopause research at The Menopause Society 2026 Annual Meeting. NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) - Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, announced today that it will present new research evaluating real-world outcomes from its Menopause and Midlife program and exhibit at The Menopause Society 2026 Annual Meeting in San Diego, October 20 - 24, 2026. As a leading provider of employer-sponsored menopause care around the globe, Progyny is committed to expanding access to high quality, evidence-based care and demonstrating its impact on women's health outcomes. The research, "Scaling Access to Menopause Care: Real-World Symptom Improvement in an Employer-Sponsored Program," will be presented by Gloria Richard-Davis, MD, MBA, Regional Dean at Morehouse School of Medicine, member of Progyny's Medical Advisory Board, and former Secretary and two-term member of The Menopause Society's Board of Trustees. The study was conducted in partnership with Morehouse School of Medicine and evaluated access, engagement, and changes in menopause symptoms among women participating in Progyny's employer-sponsored Menopause and Midlife program. "Menopause is a significant health transition, yet too many women still struggle to find clinicians with the expertise to provide individualized, evidence-based care," said Janet Choi, MD, Chief Medical Officer, Progyny. "This research demonstrates the potential to translate menopause expertise into a model that can reach more women and meaningfully improve their symptoms. That's an important step toward making high-quality menopause care a more accessible part of women's healthcare." Progyny's participation in The Menopause Society Annual Meeting reflects the company's continued expansion of its clinical research and solutions across the entire women's health spectrum. Building on more than a decade of experience in fertility and family building, Progyny now supports members across the reproductive health continuum, including preconception, fertility, pregnancy, postpartum, and menopause and midlife. Dr. Richard-Davis will present the research during Concurrent Session #2 on Thursday, October 22, from 5:15-5:30 PM PT. The Progyny team will be at Booth #211 if there is interest to learn more about its Menopause and Midlife program and broader women's health offerings. To learn more about Progyny's Menopause and Midlife offering, please visit Progyny.com/menopausesupport About Progyny Progyny is a global leader in women's health and family building solutions, trusted by leading employers, health plans, and benefit purchasers worldwide. Through its comprehensive and personalized approach, Progyny supports members across fertility and family building, pregnancy and postpartum, menopause and midlife, and parent and child well-being journeys. Progyny combines differentiated clinical care, integrated pharmacy support through Progyny Rx(R), and personalized guidance from Progyny Care Advocates(R) to deliver improved member experiences and better health outcomes. For more information, visit www.progyny.com. For Further Information, Please Contact: Alexis Ford Investors: James Hart Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Military Industry Today do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Progyny
Sep 4th, 2026
How culturally responsive care is helping reduce disparities in fertility treatment.

How culturally responsive care is helping reduce disparities in fertility treatment. Fertility care is deeply personal. Every patient brings unique experiences, values, and cultural perspectives to their care. Yet many patients from historically marginalized communities report feeling unwelcome or misunderstood in healthcare environments where their lived experiences were not reflected in the care they received. While many factors contribute to these experiences, one is the longstanding lack of diversity within the healthcare workforce. Although women make up about half of the U.S. population and Black Americans nearly 14%, physicians remain disproportionately white and male-only 39% of practicing physicians are female, and just about 5% are Black. For many people seeking fertility treatment, having the option to receive care from a provider who understands their background and respects their values, preferences and lived experiences can help foster trust, communication, and engagement during treatment. Choice in care matters. In response, Janet Choi, MD, Progyny Chief Medical Officer, and other network physicians collaborated with Morehouse School of Medicine, Ferring Pharmaceuticals, and EngagedMD to develop educational content focused on advancing culturally responsive fertility care. The FertilityEquity(TM) training program is comprised of 26 evidence-based learning modules combining educational content, practical guidance, and real patient stories illustrating care gaps. The curriculum explores disparities in fertility care and delivers actionable strategies to support more equitable patient experiences and outcomes. Providers and clinics completing the coursework are recognized in the Progyny Provider Search Tool, enabling members to identify practices that have demonstrated a commitment to culturally responsive care. "Members can now more easily identify providers who have invested in culturally responsive fertility care, which is essential to improving both trust and outcomes. For many patients-particularly women of color-experiences of feeling dismissed or not fully heard remain far too common, and that can delay engagement with care at critical moments," explains Dr. Choi. The need for this type of support is reflected in persistent disparities in fertility care. Research shows that while Black women experience infertility at disproportionately higher rates, they often seek fertility care later and face greater barriers to accessing treatment. Black women may spend more than 1.5 additional years trying to conceive before seeking fertility support and are significantly more likely to report difficulty finding a preferred provider. Additionally, Black and Hispanic women are up to six times more likely to have difficulty finding a physician with whom they feel comfortable. By helping members identify providers who have completed culturally responsive care training, Progyny aims to make it easier for individuals to find care that aligns with their needs and fosters trust throughout the fertility journey. "Age is a significant factor that influences the success of fertility interventions and pregnancy outcomes. It is critical that disparities-and resultant barriers-don't contribute to delays in seeking care, particularly for historically underserved populations," says Gloria Richard-Davis, MD, MBA, Regional Dean of the Morehouse School of Medicine and Progyny Medical Advisory Board member. "With the opportunity to identify aligned providers, members can seek fertility care earlier and with greater confidence." Strong provider-patient relationships are foundational to high-quality fertility care. When patients feel heard, respected, and understood, they are more likely to engage in their care, make informed decisions, and feel empowered throughout their fertility journey. The response to the coursework has been overwhelmingly positive; participants eager to pursue the recognized culturally competent care designation to better meet the needs of diverse patient populations. Progyny's partnership with Morehouse, Ferring, and EngagedMD reflects a broader effort to raise the standard of care-ensuring that more individuals can access providers who understand their needs, engage earlier in treatment, and ultimately achieve better outcomes. This is an important step toward a future where every patient feels seen, heard, and supported throughout their fertility journey. If you're curious to learn more or if you're a provider looking to take the course, please visit FertilityEquity.

Yahoo Finance
Aug 12th, 2026
2 cash-heavy stocks to watch and 1 to avoid

Two healthcare companies with strong cash positions are attracting investor attention, whilst a fertility benefits provider faces challenges. Progyny holds $214.4 million in net cash, representing 14.2% of its market capitalisation. However, the company has struggled with underwhelming unit sales over the past two years and demonstrates below-average returns on capital. Trading at $27.95 per share, Progyny commands a 13.9x forward price-to-earnings ratio. Molina Healthcare maintains a net cash position of $1.22 billion, or 11.9% of market cap. The managed healthcare provider has achieved 13.7% annual revenue growth over five years, outpacing sector averages. Operating across 21 states, Molina serves low-income individuals through Medicaid, Medicare, and Marketplace programmes. Axos Financial, a digital banking and financial services company, holds $39.48 million in net cash, though this represents just 0.7% of its market capitalisation.

Market Wire News
Aug 7th, 2026
Progyny, Inc. to present at the Canaccord Genuity Annual Growth Conference.

Progyny, Inc. to present at the Canaccord Genuity Annual Growth Conference. August 07, 2026 10:51:30 am NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) - Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET. Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny's investor relations website at http://investors.progyny.com. About Progyny Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. Market Wire News envision a world where everyone can realize their dreams of family and ideal health. Its outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians. Its benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain's Fast 50 for NYC. For more information, visit www.progyny.com. For Further Information, Please Contact: Investors: James Hart [email protected] Media: Alexis Ford [email protected]

Yahoo Finance
Aug 7th, 2026
Progyny hits record EBITDA with revenue up 11%, repurchases $31.5M in shares

Progyny reported record quarterly revenue and adjusted EBITDA for Q2 2026. Second quarter revenue rose 5.3% year-over-year, or 11% excluding contributions from a large former client under a transition agreement in Q2 2025. The fertility benefits provider's gross margin expanded 180 basis points year-over-year, driven by efficiencies in care management and service delivery. Operating cash flow reached more than $50 million for the fourth time in five quarters. Progyny repurchased nearly 1.2 million shares for $31.5 million during the quarter under its $200 million programme. Since November, the company has bought back 10.8 million shares, reducing shares outstanding by approximately 12.5%. The company projects full-year 2026 revenue between $1.36 billion and $1.385 billion, representing growth of 5.5% to 7.5%.